EUVIMEDEUVIMED entdecken
Fallbericht

Integrative Unani pharmacotherapy in chronic gastroesophageal reflux disease: A case report

Sabiha Fatima, Shaik Asgar

EXPLORE · 2026

DOI: 10.1016/j.explore.2026.103319 ↗

Kurz gefasst

Fallbericht in der Zeitschrift EXPLORE, 2026. Verfasst von Sabiha Fatima und 1 weiteren Autor:innen. Beteiligte Einrichtung: Assistant Professor, Department of Moalajat, National Institute of Unani Medicine, Ghaziabad, India. Electronic address: sabihafatima11@yahoo.com. Hauptthemen laut MEDLINE: Gastroesophageal Reflux. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder that often requires prolonged proton pump inhibitor (PPI) therapy. It frequently coexists with Helicobacter pylori-associated gastritis. Limitations of long-term PPI use, symptom recurrence, and patient adherence have increased interest in complementary medical systems. Unani system of medicine (USM) conceptualizes reflux-like disorders as disturbances of digestion and gastric temperament, emphasizing mucosal protection and physiological restoration. CASE PRESENTATION: A 39-year-old man with a four-year history of severe GERD presented with persistent heartburn, regurgitation, epigastric burning, nausea, and sleep disturbance. Baseline investigations revealed H. pylori associated pangastritis in endoscopy, and Grade II-III reflux on barium swallow. After a brief course of conventional triple therapy for background gastritis, a structured 12-week Unani regimen was initiated as the primary intervention for GERD. Lifestyle corrections and dietary counseling were also provided. PPI therapy was discontinued after two weeks. Clinical symptoms, quality of life scores, imaging findings, and safety parameters were monitored. RESULTS: The patient demonstrated progressive and clinically meaningful improvement with marked reduction in GERD-HRQL scores. Follow-up endoscopy showed descriptive improvement in gastric mucosa, and barium swallow findings normalized by week 14. The laboratory test results remained normal, and no adverse effects were reported. Clinical improvement was maintained at six-month follow-up without PPI use. CONCLUSION: In this case, a structured Unani regimen administered after short-term conventional therapy was temporally associated with improvement in chronic GERD symptoms and functional outcomes. Although gastritis improved descriptively, post-treatment H. pylori eradication was not assessed. Given the inherent limitations of a single-patient design, controlled clinical studies are required to confirm the efficacy and elucidate the mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxHumansMaleAdultProton Pump InhibitorsHelicobacter InfectionsChronic DiseaseHelicobacter pyloriGastritisQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

Case reportGastroesophageal reflux diseaseIntegrative medicinePangastritisUnani system of medicine

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Assistant Professor, Department of Moalajat, National Institute of Unani Medicine, Ghaziabad, India. Electronic address: sabihafatima11@yahoo.com.
  • PG Scholar, Department of Moalajat, National Institute of Unani Medicine, Ghaziabad, India.

Zitieren

APA

Fatima, S., & Asgar, S. (2026). Integrative Unani pharmacotherapy in chronic gastroesophageal reflux disease: A case report. EXPLORE. https://doi.org/10.1016/j.explore.2026.103319

Vancouver

Fatima S, Asgar S. Integrative Unani pharmacotherapy in chronic gastroesophageal reflux disease: A case report. EXPLORE. 2026. doi:10.1016/j.explore.2026.103319

BibTeX
@article{Fatima2026,
  author = {Fatima, Sabiha and Asgar, Shaik},
  title = {Integrative Unani pharmacotherapy in chronic gastroesophageal reflux disease: A case report},
  journal = {EXPLORE},
  year = {2026},
  doi = {10.1016/j.explore.2026.103319}
}
Kostenlos starten →